Kim Suk-Jeong, Kim Ji-Eun, Kim Yong-Woon, Kim Jong-Yeon, Park So-Young
Department of Physiology, College of Medicine, Yeungnam University, Daegu, Republic of Korea; and.
Smart-Aging Convergence Research Center, College of Medicine, Yeungnam University, Daegu, Republic of Korea.
Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F887-F898. doi: 10.1152/ajprenal.00594.2016. Epub 2017 May 24.
Regulation of lipogenesis by pathophysiological factors in the liver and skeletal muscle is well understood; however, regulation in the kidney is still unclear. To elucidate nutritional regulation of lipogenic factors in the kidney, we measured the renal expression of lipogenic transcriptional factors and enzymes during fasting and refeeding in chow-fed and high-fat-fed mice. We also examined the regulatory effect of the liver X receptor (LXR) on the expression of lipogenic factors. The renal gene expression of sterol regulatory element-binding protein (SREBP)-1c and fatty acid synthase (FAS) was reduced by fasting for 48 h and restored by refeeding, whereas the mRNA levels of forkhead box O (FOXO)1/3 were increased by fasting and restored by refeeding. Accordingly, protein levels of SREBP-1, FAS, and phosphorylated FOXO1/3 were reduced by fasting and restored by refeeding. The patterns of lipogenic factors expression in the kidney were similar to those in the liver and skeletal muscle. However, this phasic regulation of renal lipogenic gene expression was blunted in diet-induced obese mice. LXR agonist TO901317 increased the lipogenic gene expression and the protein levels of SREBP-1 precursor and FAS but not nuclear SREBP-1. Moreover, increases in insulin-induced gene mRNA and nuclear carbohydrate-responsive element binding protein (ChREBP) levels were observed in the TO901317-treated mice. These results suggest that the kidney shows flexible suppression and restoration of lipogenic factors following fasting and refeeding in lean mice, but this is blunted in obese mice. LXR is involved in the renal expression of lipogenic enzymes, and ChREBP may mediate the response.
肝脏和骨骼肌中病理生理因素对脂肪生成的调控已为人熟知;然而,肾脏中的调控情况仍不清楚。为了阐明肾脏中脂肪生成因子的营养调控,我们在正常饮食喂养和高脂喂养的小鼠禁食和再喂养期间,测量了脂肪生成转录因子和酶的肾脏表达。我们还研究了肝脏X受体(LXR)对脂肪生成因子表达的调控作用。禁食48小时可降低固醇调节元件结合蛋白(SREBP)-1c和脂肪酸合酶(FAS)的肾脏基因表达,再喂养可使其恢复,而叉头框O(FOXO)1/3的mRNA水平在禁食时升高,再喂养时恢复。相应地,SREBP-1、FAS和磷酸化FOXO1/3的蛋白质水平在禁食时降低,再喂养时恢复。肾脏中脂肪生成因子的表达模式与肝脏和骨骼肌中的相似。然而,在饮食诱导的肥胖小鼠中,肾脏脂肪生成基因表达的这种阶段性调控减弱。LXR激动剂TO901317增加了脂肪生成基因的表达以及SREBP-1前体和FAS的蛋白质水平,但不增加核SREBP-1的水平。此外,在TO901317处理的小鼠中,观察到胰岛素诱导基因mRNA和核碳水化合物反应元件结合蛋白(ChREBP)水平升高。这些结果表明,在瘦小鼠中,肾脏在禁食和再喂养后对脂肪生成因子表现出灵活的抑制和恢复,但在肥胖小鼠中这种情况减弱。LXR参与脂肪生成酶的肾脏表达,ChREBP可能介导该反应。